Arbutus Biopharma Corporation
ABUS
$4.31
-$0.08-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -25.40% | -26.68% | -30.92% | -12.79% | -2.68% |
| Total Receivables | -35.51% | -36.84% | -45.57% | -49.54% | 14.02% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -37.60% | -17.56% | -6.26% | -30.16% | -45.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -25.81% | -26.61% | -30.43% | -14.03% | -3.57% |
|
|
|||||
| Total Current Assets | -25.81% | -26.61% | -30.43% | -14.03% | -3.57% |
| Net Property, Plant & Equipment | -99.27% | -97.09% | -97.21% | -97.07% | -28.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 282.35% | -- | -- | -- | -- |
| Total Assets | -28.16% | -30.43% | -35.48% | -22.14% | -8.79% |
|
|
|||||
| Total Accounts Payable | -49.35% | -56.33% | -50.19% | -40.15% | -28.14% |
| Total Accrued Expenses | -30.53% | -38.27% | -71.39% | -13.32% | -25.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.25% | 13.46% | 13.47% | 12.15% | 13.65% |
| Total Finance Division Other Current Liabilities | -91.55% | -93.35% | -93.04% | 10.19% | -35.79% |
| Total Other Current Liabilities | -91.55% | -93.35% | -93.04% | 10.19% | -35.79% |
| Total Current Liabilities | -61.54% | -72.60% | -77.77% | -4.26% | -30.55% |
|
|
|||||
| Total Current Liabilities | -61.54% | -72.60% | -77.77% | -4.26% | -30.55% |
| Long-Term Debt | -28.72% | -30.69% | -33.27% | -31.07% | -30.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -75.31% | -60.02% | -49.74% | -46.99% | -39.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -35.86% | 32.60% | 34.95% | 72.07% | 72.21% |
| Total Liabilities | -47.46% | -39.46% | -46.02% | 6.17% | -10.53% |
|
|
|||||
| Common Stock & APIC | 0.85% | 0.86% | 0.99% | 2.81% | 4.26% |
| Retained Earnings | -2.49% | -3.17% | -4.13% | -5.91% | -5.48% |
| Treasury Stock & Other | 0.08% | -0.08% | 0.25% | 0.42% | 0.59% |
| Total Common Equity | -21.35% | -27.59% | -32.24% | -30.95% | -8.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.35% | -27.59% | -32.24% | -30.95% | -8.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.35% | -27.59% | -32.24% | -30.95% | -8.16% |
|
|
|||||